PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer


NCT01899599

Interventional

Phase 2

Unknown status
Efficacy of PankoMab-GEX vs Placebo in maintaining a response to chemotherapy in advanced ovarian, fallopian tube or primary peritoneal cancer.
Sep 30,2013
Female
18 Years
N/A
216

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.